Patterson Companies, Inc. (0KGB.L)
USD 31.29
(1.45%)
USD 31.29
(1.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 328.91 Million USD | -27.11% |
| 2023 | 518.6 Million USD | -2.5% |
| 2022 | 531.88 Million USD | -0.74% |
| 2021 | 535.86 Million USD | -15.96% |
| 2020 | 637.62 Million USD | -12.09% |
| 2019 | 725.34 Million USD | -21.33% |
| 2018 | 922.03 Million USD | -7.64% |
| 2017 | 998.27 Million USD | -2.34% |
| 2016 | 1.02 Billion USD | 40.99% |
| 2015 | 725 Million USD | 0.0% |
| 2014 | 725 Million USD | 0.0% |
| 2013 | 725 Million USD | 0.0% |
| 2012 | 725 Million USD | 38.1% |
| 2011 | 525 Million USD | 0.0% |
| 2010 | 525 Million USD | 0.0% |
| 2009 | 525 Million USD | -0.0% |
| 2008 | 525.02 Million USD | 303.83% |
| 2007 | 130.01 Million USD | -38.09% |
| 2006 | 210.01 Million USD | -30.35% |
| 2005 | 301.53 Million USD | -37.12% |
| 2004 | 479.55 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 1.7 Million USD | -37.04% |
| 1998 | 2.7 Million USD | -3.57% |
| 1997 | 2.8 Million USD | -6.67% |
| 1996 | 3 Million USD | -6.25% |
| 1995 | 3.2 Million USD | -64.04% |
| 1994 | 8.9 Million USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 17.5 Million USD | -12.94% |
| 1991 | 20.1 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 448.21 Million USD | -0.39% |
| 2024 FY | 328.91 Million USD | -36.58% |
| 2024 Q1 | 523 Million USD | -0.14% |
| 2024 Q2 | 524.36 Million USD | -0.14% |
| 2024 Q4 | 328.91 Million USD | -26.62% |
| 2023 Q3 | 500.89 Million USD | -6.11% |
| 2023 Q4 | 518.6 Million USD | 3.54% |
| 2023 Q1 | 536.26 Million USD | 0.82% |
| 2023 FY | 518.6 Million USD | -2.5% |
| 2023 Q2 | 533.5 Million USD | -0.51% |
| 2022 Q3 | 531.86 Million USD | -0.27% |
| 2022 Q2 | 533.3 Million USD | -0.6% |
| 2022 Q1 | 536.53 Million USD | 0.13% |
| 2022 FY | 531.88 Million USD | -0.74% |
| 2022 Q4 | 531.88 Million USD | 0.0% |
| 2021 Q1 | 635.81 Million USD | -0.28% |
| 2021 Q2 | 642.12 Million USD | 0.99% |
| 2021 Q4 | 535.86 Million USD | -0.67% |
| 2021 FY | 535.86 Million USD | -15.96% |
| 2021 Q3 | 539.49 Million USD | -15.98% |
| 2020 Q2 | 717.44 Million USD | -7.33% |
| 2020 Q1 | 774.17 Million USD | 6.73% |
| 2020 Q3 | 640.86 Million USD | -10.67% |
| 2020 Q4 | 637.62 Million USD | -0.51% |
| 2020 FY | 637.62 Million USD | -12.09% |
| 2019 Q1 | 743.7 Million USD | -19.34% |
| 2019 FY | 725.34 Million USD | -21.33% |
| 2019 Q3 | 732.64 Million USD | -0.77% |
| 2019 Q4 | 725.34 Million USD | -1.0% |
| 2019 Q2 | 738.34 Million USD | -0.72% |
| 2018 Q4 | 922.03 Million USD | -1.01% |
| 2018 Q2 | 991.23 Million USD | -0.72% |
| 2018 Q1 | 998.45 Million USD | 0.02% |
| 2018 FY | 922.03 Million USD | -7.64% |
| 2018 Q3 | 931.41 Million USD | -6.03% |
| 2017 Q1 | 1.01 Billion USD | -0.58% |
| 2017 FY | 998.27 Million USD | -2.34% |
| 2017 Q4 | 998.27 Million USD | -0.35% |
| 2017 Q3 | 1 Billion USD | -0.84% |
| 2017 Q2 | 1.01 Billion USD | -0.59% |
| 2016 Q2 | 1.03 Billion USD | -40.01% |
| 2016 Q1 | 1.72 Billion USD | 137.93% |
| 2016 FY | 1.02 Billion USD | 40.99% |
| 2016 Q4 | 1.02 Billion USD | -0.79% |
| 2016 Q3 | 1.03 Billion USD | -0.45% |
| 2015 FY | 725 Million USD | 0.0% |
| 2015 Q4 | 725 Million USD | 0.0% |
| 2015 Q1 | 725 Million USD | 0.0% |
| 2015 Q2 | 725 Million USD | 0.0% |
| 2015 Q3 | 725 Million USD | 0.0% |
| 2014 Q1 | 725 Million USD | 0.0% |
| 2014 Q2 | 725 Million USD | 0.0% |
| 2014 Q3 | 725 Million USD | 0.0% |
| 2014 FY | 725 Million USD | 0.0% |
| 2014 Q4 | 725 Million USD | 0.0% |
| 2013 Q3 | 725 Million USD | 0.0% |
| 2013 Q2 | 725 Million USD | 0.0% |
| 2013 Q1 | 725 Million USD | 0.0% |
| 2013 Q4 | 725 Million USD | 0.0% |
| 2013 FY | 725 Million USD | 0.0% |
| 2012 FY | 725 Million USD | 38.1% |
| 2012 Q3 | 850 Million USD | 61.9% |
| 2012 Q4 | 725 Million USD | -14.71% |
| 2012 Q2 | 525 Million USD | 0.0% |
| 2012 Q1 | 525 Million USD | 0.0% |
| 2011 Q1 | 525 Million USD | 0.0% |
| 2011 Q4 | 525 Million USD | 0.0% |
| 2011 Q3 | 525 Million USD | 0.0% |
| 2011 FY | 525 Million USD | 0.0% |
| 2011 Q2 | 525 Million USD | 0.0% |
| 2010 Q1 | 525 Million USD | 0.0% |
| 2010 FY | 525 Million USD | 0.0% |
| 2010 Q4 | 525 Million USD | 0.0% |
| 2010 Q3 | 525 Million USD | 0.0% |
| 2010 Q2 | 525 Million USD | 0.0% |
| 2009 Q2 | 525.33 Million USD | 0.06% |
| 2009 FY | 525 Million USD | -0.0% |
| 2009 Q3 | 525.04 Million USD | -0.06% |
| 2009 Q4 | 525 Million USD | -0.01% |
| 2009 Q1 | 525.02 Million USD | 0.0% |
| 2008 FY | 525.02 Million USD | 303.83% |
| 2008 Q1 | 130.07 Million USD | 0.05% |
| 2008 Q2 | 130.06 Million USD | -0.01% |
| 2008 Q3 | 60.05 Million USD | -53.83% |
| 2008 Q4 | 525.02 Million USD | 774.21% |
| 2007 Q4 | 130.01 Million USD | -10.35% |
| 2007 FY | 130.01 Million USD | -38.09% |
| 2007 Q1 | 205.01 Million USD | -2.38% |
| 2007 Q2 | 200 Million USD | -2.44% |
| 2007 Q3 | 145.01 Million USD | -27.5% |
| 2006 Q1 | 296.52 Million USD | -1.66% |
| 2006 Q2 | 290.01 Million USD | -2.19% |
| 2006 Q3 | 285.02 Million USD | -1.72% |
| 2006 Q4 | 210.01 Million USD | -26.32% |
| 2006 FY | 210.01 Million USD | -30.35% |
| 2005 Q2 | 416.54 Million USD | -11.67% |
| 2005 FY | 301.53 Million USD | -37.12% |
| 2005 Q4 | 301.53 Million USD | -26.73% |
| 2005 Q3 | 411.53 Million USD | -1.2% |
| 2005 Q1 | 471.54 Million USD | -1.67% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | 484.56 Million USD | 0.0% |
| 2004 Q4 | 479.55 Million USD | -1.03% |
| 2004 FY | 479.55 Million USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q1 | 1.5 Million USD | -11.76% |
| 2000 Q4 | - USD | -100.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q3 | 1.4 Million USD | 0.0% |
| 2000 Q2 | 1.4 Million USD | -6.67% |
| 1999 Q1 | 2.7 Million USD | 0.0% |
| 1999 Q4 | 1.7 Million USD | 13.33% |
| 1999 FY | 1.7 Million USD | -37.04% |
| 1999 Q2 | 2.6 Million USD | -3.7% |
| 1999 Q3 | 1.5 Million USD | -42.31% |
| 1998 Q3 | 2.8 Million USD | -26.32% |
| 1998 Q4 | 2.7 Million USD | -3.57% |
| 1998 FY | 2.7 Million USD | -3.57% |
| 1998 Q1 | 2.9 Million USD | 3.57% |
| 1998 Q2 | 3.8 Million USD | 31.03% |
| 1997 FY | 2.8 Million USD | -6.67% |
| 1997 Q2 | 3 Million USD | 0.0% |
| 1997 Q1 | 3 Million USD | 0.0% |
| 1997 Q4 | 2.8 Million USD | -3.45% |
| 1997 Q3 | 2.9 Million USD | -3.33% |
| 1996 Q4 | 3 Million USD | 0.0% |
| 1996 Q1 | 3.1 Million USD | -3.13% |
| 1996 Q2 | 3.1 Million USD | 0.0% |
| 1996 Q3 | 3 Million USD | -3.23% |
| 1996 FY | 3 Million USD | -6.25% |
| 1995 Q3 | 3.1 Million USD | -6.06% |
| 1995 Q4 | 3.2 Million USD | 3.23% |
| 1995 FY | 3.2 Million USD | -64.04% |
| 1995 Q1 | 3.4 Million USD | -61.8% |
| 1995 Q2 | 3.3 Million USD | -2.94% |
| 1994 Q3 | 5.6 Million USD | -44.55% |
| 1994 Q2 | 10.1 Million USD | 0.0% |
| 1994 Q4 | 8.9 Million USD | 58.93% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | 8.9 Million USD | 0.0% |
| 1993 Q3 | - USD | -100.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q2 | 16.1 Million USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1992 Q4 | 17.5 Million USD | 0.0% |
| 1992 FY | 17.5 Million USD | -12.94% |
| 1991 FY | 20.1 Million USD | 0.0% |
| 1991 Q4 | 20.1 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -15952.269% |
| Accuray Incorporated | 164.4 Million USD | -100.068% |
| Align Technology, Inc. | 96.96 Million USD | -239.195% |
| Elevance Health Inc. | 23.24 Billion USD | 98.585% |
| AxoGen, Inc. | 46.6 Million USD | -605.772% |
| Boston Scientific Corporation | 8.56 Billion USD | 96.16% |
| CVS Health Corporation | 74.67 Billion USD | 99.56% |
| Cardinal Health, Inc. | 4.58 Billion USD | 92.823% |
| Centene Corporation | 17.69 Billion USD | 98.142% |
| DaVita Inc. | 8.05 Billion USD | 95.915% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 99.102% |
| Hologic, Inc. | 2.49 Billion USD | 86.828% |
| Humana Inc. | 10.21 Billion USD | 96.779% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 47.195% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 91.888% |
| Masimo Corporation | 871.7 Million USD | 62.268% |
| McKesson Corporation | 5.45 Billion USD | 93.966% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 92.542% |
| ResMed Inc. | 697.31 Million USD | 52.832% |
| Henry Schein, Inc. | 1.93 Billion USD | 82.984% |
| Teladoc Health, Inc. | 1.58 Billion USD | 79.203% |
| Universal Health Services, Inc. | 4.71 Billion USD | 93.026% |
| Veeva Systems Inc. | 46.44 Million USD | -608.234% |
| Baxter International Inc. | 11.06 Billion USD | 97.027% |
| Becton, Dickinson and Company | 14.73 Billion USD | 97.768% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 500.622% |
| Danaher Corporation | 17.66 Billion USD | 98.138% |
| Stryker Corporation | 10.9 Billion USD | 96.983% |
| Medtronic plc | 23.87 Billion USD | 98.622% |